Synthesis and Optimization of the Aleutianamine Class of Alkaloids
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
批准号:
10799135
负责人:
Mark T Hamann
金额:
$16.57万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2026-06-30
关键词:
AlaskaAleutian IslandsAlkaloidsAnabolismApplied ResearchArctic RegionsBasic ScienceBiological ModelsChemicalsChemistryConstruction MaterialsDataDevelopmentDiseaseDisease ManagementEnvironmentGenerationsGrantInflammationInvestigationMalariaMethodologyModelingNational Oceanic and Atmospheric AdministrationNatural ProductsParentsPenetrationPharmaceutical PreparationsPharmacologyPlayPoriferaRouteTherapeuticTissuesViral CancerVirus Diseasesbioactive natural productscold temperaturedeep oceandesignequipment acquisitioniminoquinonein vivoinnovationmarinemarine organismmembermetabolomicsocean ecosystemsparent grantpressureprogramsresearch and developmentsmall moleculeultraviolet irradiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
There is a tremendous unmet need for effective synthesis methodologies and strategies for the construction of
aleutianamine and other members of the discorhabdin class of natural products. This has significantly hindered
the mechanistic, basic and applied science studies for this unique class of alkaloids which offers significant
value in the control of a variety of diseases and clearly warrants additional basic research into the synthesis,
mechanism of action and basic pharmacology. Natural Products (NPs) have played a key role as therapeutics
for a variety of diseases and the data presented in this application reveals the tremendous potential for these
molecules. After 25 years of studying marine organisms for new and innovative chemistry we have identified a
single truly remarkable molecule called aleutianamine. Aleutianamine has been recovered from a Latrunculia
sponge collected from the deep ocean off the coast of the Aleutian Islands by NOAA Alaska. We have
exhaustively interrogated extracts for any detectable quantities of this molecule and the only remaining option
to generate mechanistic and in vivo data is to first generate the drug through a reliable synthesis. This molecule
is extremely unique chemically and is a member of two very rare groups of bioactive natural products including
the iminoquinones and the thioalkaloids and is certain to be a product of the extreme conditions of these deep
ocean environments where cold temperatures, high pressure, and anoxic conditions deplete of UV irradiation
provides a unique environment for biosynthesis and rearrangement to form highly unusual molecules.
Aleutianamine and other members of this class as well as their synthetic intermediates offer unique controls for
a diversity of diseases including malaria, inflammation, viral diseases and cancer strongly supporting the
development of strategies to provide consistent supply of the drug and approaches to the generation and
diversification of the class. Due to the rare and limited supply of this molecule the specific aims of this program
involve the development of synthesis methodologies using two different routes in addition to the isolation and
characterization of starting materials and related molecules for SAR and investigations into alternative
approaches involving biosynthetic starting materials for the construction and optimization of the molecule.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
-
批准号:10345968
-
项目类别:
-
资助金额:$56.07万
-
财政年份:2022
-
负责人:Mark T Hamann
-
依托单位:
Support for Graduate, PDF and New Faculty Presenters at the 2022 American Society of Pharmacognosy Meeting
-
批准号:10469168
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2022
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:8707979
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:8912993
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:8541704
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:8339007
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:9230277
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
-
批准号:9127149
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2012
-
负责人:Mark T Hamann
-
依托单位:
MARINE CYSTINE KNOT PEPTIDES
-
批准号:8361215
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2011
-
负责人:Mark T Hamann
-
依托单位:
CHEMISTRY CORE
-
批准号:8167941
-
项目类别:
-
资助金额:$8.42万
-
财政年份:2010
-
负责人:Mark T Hamann
-
依托单位:
CHEMISTRY CORE
-
批准号:7959632
-
项目类别:
-
资助金额:$12.82万
-
财政年份:2009
-
负责人:Mark T Hamann
-
依托单位:
CHEMISTRY CORE
-
批准号:7720416
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2008
-
负责人:Mark T Hamann
-
依托单位:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
-
批准号:2886084
-
项目类别:
-
资助金额:$6.74万
-
财政年份:1998
-
负责人:Mark T Hamann
-
依托单位:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
-
批准号:6532596
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1998
-
负责人:Mark T Hamann
-
依托单位:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
-
批准号:6372593
-
项目类别:
-
资助金额:$9.47万
-
财政年份:1998
-
负责人:Mark T Hamann
-
依托单位:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
-
批准号:6168418
-
项目类别:
-
资助金额:$9.19万
-
财政年份:1998
-
负责人:Mark T Hamann
-
依托单位:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
-
批准号:2450444
-
项目类别:
-
资助金额:$6.74万
-
财政年份:1998
-
负责人:Mark T Hamann
-
依托单位:
ANTI AIDS AGENTS FROM MARINE ORGANISMS
-
批准号:2886946
-
项目类别:
-
资助金额:$13.46万
-
财政年份:1995
-
负责人:Mark T Hamann
-
依托单位:
ANTI AIDS AGENTS FROM MARINE ORGANISMS
-
批准号:2390408
-
项目类别:
-
资助金额:$12.6万
-
财政年份:1995
-
负责人:Mark T Hamann
-
依托单位:
ANTI AIDS AGENTS FROM MARINE ORGANISMS
-
批准号:2072951
-
项目类别:
-
资助金额:$10.63万
-
财政年份:1995
-
负责人:Mark T Hamann
-
依托单位:
海外基金